Gene: FAM124A
Official Full Name: family with sequence similarity 124 member Aprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28112 | FAM124A Knockout cell line (HCT 116) | Human | FAM124A | 1:2~1:4 | Negative | Online Inquiry |
KO28113 | FAM124A Knockout cell line (HEK293) | Human | FAM124A | 1:3~1:6 | Negative | Online Inquiry |
KO28114 | FAM124A Knockout cell line (A549) | Human | FAM124A | 1:3~1:4 | Negative | Online Inquiry |
FAM124A Gene Knockout Cell Lines are genetically modified cell lines that have been specifically engineered to have a disruption in the FAM124A gene, serving as invaluable tools for research in gene function and disease mechanisms. This product utilizes CRISPR-Cas9 technology to achieve precise gene editing, ensuring that the FAM124A gene is effectively knocked out, allowing researchers to investigate the biological implications of its loss. By utilizing these knockout models, scientists can study the role of FAM124A in various cellular processes, including cell proliferation, differentiation, and response to stress, which can be particularly relevant in the context of cancer biology and developmental studies.
The scientific importance of FAM124A Gene Knockout Cell Lines lies in their application across both research and clinical settings. They facilitate in-depth studies into the gene's functional contributions to health and disease, aid in the identification of disease biomarkers, and serve as a platform for drug discovery and therapeutic interventions. Researchers can utilize these cell lines to conduct high-throughput screening, compare cellular behavior with wild-type lines, or assess the effect of potential pharmacological agents on mutant phenotypes.
What sets FAM124A Gene Knockout Cell Lines apart from other cellular models is the specificity and efficiency of the knockouts, achieved through state-of-the-art genetic engineering techniques. This high level of precision minimizes off-target effects and enhances reproducibility, critical for generating reliable data in scientific studies. Furthermore, these cell lines are developed in accordance with rigorous quality control standards, ensuring consistent performance, which is essential for researchers aiming to draw meaningful conclusions from their experiments.
The value of FAM124A Gene Knockout Cell Lines to researchers, clinicians, and pharmaceutical companies is multi-fold. They enable the elucidation of genetic pathways that may be targeted for disease intervention, offer insight into genotype-phenotype correlations, and ultimately contribute to the advancement of personalized medicine strategies. As a company dedicated to providing innovative biological solutions, we bring years of expertise in genetic engineering and cell line development to the table, committed to supporting the scientific community with high-quality products that drive cutting-edge research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.